tiprankstipranks
Trending News
More News >

Don Agro International’s Strategic Shift to Healthcare with Euroonco Acquisition

Story Highlights
  • Don Agro is shifting focus from agriculture to healthcare, acquiring Euroonco clinics.
  • The acquisition reflects a strategic reorientation, with due diligence on risks involved.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Don Agro International’s Strategic Shift to Healthcare with Euroonco Acquisition

Don’t Miss TipRanks’ Half-Year Sale

An announcement from Don Agro International Limited ( (SG:GRQ) ) is now available.

Don Agro International Limited is responding to queries from the Securities Investors Association (Singapore) regarding its 2024 Annual Report. The company is in the process of acquiring Euroonco, a prominent oncology clinic network in Russia, as part of its strategic shift towards healthcare. This acquisition aligns with its goal of creating social value and reflects a significant reorientation of its business activities. The company has conducted due diligence on the acquisition, considering geopolitical and operational risks, but there is no certainty the acquisition will be completed.

More about Don Agro International Limited

Don Agro International Limited, incorporated in Singapore, is transitioning from its traditional agricultural focus to the healthcare sector. The company is leveraging its leadership’s experience in healthcare to expand into medical services, particularly through acquisitions like Euroonco, a network of oncology clinics in Russia.

YTD Price Performance: -29.00%

Average Trading Volume: 28,980

Technical Sentiment Signal: Buy

Current Market Cap: S$21.34M

See more data about GRQ stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1